The Claim
A panel of five senescence-associated biomarkers—activin A, ICAM1, MMP7, VEGFA, and eotaxin—combined with age, sex, race, and BMI, predicts mobility disability (SPPB ≤7) with 86% accuracy in older adults, and this predictive accuracy exceeds that of demographic factors alone.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults, a combination of five biological markers along with age, sex, race, and body mass index can accurately identify those with reduced mobility, correctly classifying 86% of cases.
See the scientific wording
A panel of five senescence-associated biomarkers—activin A, ICAM1, MMP7, VEGFA, and eotaxin—combined with age, sex, race, and BMI, can predict mobility disability (SPPB ≤7) with 86% accuracy in older adults, outperforming demographic factors alone.
As people age, damaged cells stop dividing and release a mix of harmful proteins that cause chronic inflammation, break down muscle and blood vessel structures, and block muscle repair. This weakens muscles, slows movement, and reduces balance, making it harder to walk or stand without help.
What the research says
1 studyScientists found that by measuring five specific proteins in the blood along with a person’s age, sex, and body weight, they could predict with 86% accuracy which older adults are at high risk for serious mobility problems—much better than using just age and sex alone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.